Parkinson's Disease Trial, Recruiting NCT07187843 Sponsor: Azienda USL Reggio Emilia - IRCCS Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07187843
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease using an established set of medical diagnostic guidelines, and who have been assessed to determine whether their Parkinson's started in the brain or in the body's internal organs — this is determined using a sleep study, a type of brain scan, and a heart imaging test.
  • People who are willing and able to give their free and informed agreement to take part in the trial.
  • People who are 18 years of age or older.

Who may not be able to join:

  • People who are unable to give their free and informed agreement to take part.
  • People whose Parkinson's disease diagnosis is considered uncertain by their treating doctor.
  • People who are under 18 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda USL Reggio Emilia - IRCCS
Registry
ClinicalTrials.gov
Start date
4 September 2024
Est. completion
30 October 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Assessment of the progression of axial symptoms; Risk of falling in the two subgroups, brain-first and body-first; Risk of falling in the two subgroups, brain-first and body-first; Assessment of the progression of axial symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov